Lv5
970 积分 2023-10-18 加入
Mode of Nipocalimab Action and Pharmacology in Cells and Preclinical Models
27天前
已关闭
Nipocalimab a High Affinity, Immunoselective Clinical FcRn Blocker with Unique Properties: Observations from Non-clinical and Clinical Studies (P4-14.008)
27天前
已关闭
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
28天前
已完结
A passionate kiss, then run: exocytosis and recycling of IgG by FcRn
1个月前
已完结
Comparing the Lectin and Mass Spectrometry-Based Approaches to Quantify Galactose-Deficient IgA1 in IgA Nephropathy
1个月前
已关闭
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases
2个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
2个月前
已完结
Preclinical safety profile of RC88-ADC：a novel mesothelin-targeted antibody conjugated with Monomethyl auristatin E
2个月前
已完结
Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1
2个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
3个月前
已完结
皖公网安备34019202002308
